Ryan Deschner
Stock Analyst at Raymond James
(0)
# 4594
Out of 5,240 analysts
7
Total ratings
50.00%
Success rate
-16.68%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARS Pharmaceuticals | Maintains: Strong Buy | 26 28 | 11.58 | 141.8% | 3 | Jan 14, 2025 | |
Trevi Therapeutics | Initiates Coverage On: Outperform | 9 | 3.85 | 133.77% | 1 | Aug 30, 2024 | |
Liquidia | Upgrades: Strong Buy | 27 27 | 11.57 | 133.36% | 2 | Aug 19, 2024 | |
Omega Therapeutics | Initiates Coverage On: Outperform | 12 | 0.63 | 1804.76% | 1 | Jun 18, 2024 |